Search research articles
Contact Us
Filters
Showing results (201-210 of 441) with videos related to
Page
of 45
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 19, 2018
From the Past to the Present: Insurer Coverage Frameworks for Next-Generation Tumor Sequencing
Julia R Trosman, Christine B Weldon, William J Gradishar, et al.
Cell Cycle (Georgetown, Tex.)
|
June 19, 2018
Caloric restriction counteracts chemotherapy-induced inflammation and increases response to therapy in a triple negative breast cancer model
Brittany A Simone, Ajay Palagani, Kimberly Strickland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 15, 2009
Epidermal growth factor receptor tyrosine kinase inhibitor reverses mesenchymal to epithelial phenotype and inhibits metastasis in inflammatory breast cancer
Dongwei Zhang, Tiffany A LaFortune, Savitri Krishnamurthy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2006
Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors
Valentina Guarneri, Kristine Broglio, Shu-Wan Kau, et al.
International Journal of Cancer
|
October 13, 2009
Chemosensitivity profile assay of circulating cancer cells: prognostic and predictive value in epithelial tumors
Paola Gazzaniga, Giuseppe Naso, Angela Gradilone, et al.
Cancer
|
February 27, 2008
Prognostic significance of HER-2 status in women with inflammatory breast cancer
Shaheenah Dawood, Kristine Broglio, Yun Gong, et al.
Cancer
|
June 28, 2005
Epidermal growth factor receptor expression correlates with poor survival in patients who have breast carcinoma treated with doxorubicin-based neoadjuvant chemotherapy
Thomas A Buchholz, Xiaoyu Tu, K Kian Ang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 28, 2010
18F-FDG PET/CT findings and circulating tumor cell counts in the monitoring of systemic therapies for bone metastases from breast cancer
Ugo De Giorgi, Michal Mego, Eric M Rohren, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2003
High and differential expression of HER-2/neu extracellular domain in bilateral ductal fluids from women with unilateral invasive breast cancer
Henry M Kuerer, Patricia A Thompson, Savitri Krishnamurthy, et al.
Cancer
|
August 27, 2004
Prognostic value of P53, MDM-2, and MUC-1 for patients with inflammatory breast carcinoma
Erika Resetkova, Ana M Gonzalez-Angulo, Nour Sneige, et al.
Page
of 45
Search research articles
Search
Showing results (201-210 of 441) with videos related to
Sort By:
Page
of 45
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 19, 2018
From the Past to the Present: Insurer Coverage Frameworks for Next-Generation Tumor Sequencing
Julia R Trosman, Christine B Weldon, William J Gradishar, et al.
Cell Cycle (Georgetown, Tex.)
|
June 19, 2018
Caloric restriction counteracts chemotherapy-induced inflammation and increases response to therapy in a triple negative breast cancer model
Brittany A Simone, Ajay Palagani, Kimberly Strickland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 15, 2009
Epidermal growth factor receptor tyrosine kinase inhibitor reverses mesenchymal to epithelial phenotype and inhibits metastasis in inflammatory breast cancer
Dongwei Zhang, Tiffany A LaFortune, Savitri Krishnamurthy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2006
Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors
Valentina Guarneri, Kristine Broglio, Shu-Wan Kau, et al.
International Journal of Cancer
|
October 13, 2009
Chemosensitivity profile assay of circulating cancer cells: prognostic and predictive value in epithelial tumors
Paola Gazzaniga, Giuseppe Naso, Angela Gradilone, et al.
Cancer
|
February 27, 2008
Prognostic significance of HER-2 status in women with inflammatory breast cancer
Shaheenah Dawood, Kristine Broglio, Yun Gong, et al.
Cancer
|
June 28, 2005
Epidermal growth factor receptor expression correlates with poor survival in patients who have breast carcinoma treated with doxorubicin-based neoadjuvant chemotherapy
Thomas A Buchholz, Xiaoyu Tu, K Kian Ang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 28, 2010
18F-FDG PET/CT findings and circulating tumor cell counts in the monitoring of systemic therapies for bone metastases from breast cancer
Ugo De Giorgi, Michal Mego, Eric M Rohren, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2003
High and differential expression of HER-2/neu extracellular domain in bilateral ductal fluids from women with unilateral invasive breast cancer
Henry M Kuerer, Patricia A Thompson, Savitri Krishnamurthy, et al.
Cancer
|
August 27, 2004
Prognostic value of P53, MDM-2, and MUC-1 for patients with inflammatory breast carcinoma
Erika Resetkova, Ana M Gonzalez-Angulo, Nour Sneige, et al.
Page
of 45